Sai Parenterals profitability ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026
Returns
2.9%
1.0%
2.6%
5.5%
Margins
10.2%
5.7%
3.1%
3.7%
7.2%
Additional
−19.5%
2.9%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SAIPARENT₹484.05

Sai Parenterals Limited

· Pharma & Health
₹ CrorePeersINDOCOPANACEABIOHIKALWINDLASHESTERBIODCALSYNCOMFSOLARAMcap ₹2,139 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY26
31/03/2026
Returns
Return on Common Equity2.91
Return on Assets1.00
Return on Capital Employed2.57
Return on Invested Capital5.49
Margins
EBITDA Margin10.16
Operating Margin5.73
Pretax Margin3.13
Net Income Margin3.74
FCF Margin7.23
Additional
Effective Tax Rate-19.54
Sustainable Growth Rate2.91
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.